These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11087767)

  • 21. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying behavioral disturbance in Alzheimer's disease patients.
    Weiner MF; Tractenberg R; Teri L; Logsdon R; Thomas RG; Gamst A; Thal LJ
    J Psychiatr Res; 2000; 34(2):163-7. PubMed ID: 10758259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL; Jacobs D
    Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
    Ballard C; Margallo-Lana M; Juszczak E; Douglas S; Swann A; Thomas A; O'Brien J; Everratt A; Sadler S; Maddison C; Lee L; Bannister C; Elvish R; Jacoby R
    BMJ; 2005 Apr; 330(7496):874. PubMed ID: 15722369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of nonpharmacologic interventions for agitation in advanced dementia: a randomized, placebo-controlled trial.
    Cohen-Mansfield J; Thein K; Marx MS; Dakheel-Ali M; Freedman L
    J Clin Psychiatry; 2012 Sep; 73(9):1255-61. PubMed ID: 23059151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
    Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
    Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study.
    Camargos EF; Louzada LL; Quintas JL; Naves JO; Louzada FM; Nóbrega OT
    Am J Geriatr Psychiatry; 2014 Dec; 22(12):1565-74. PubMed ID: 24495406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.
    Cummings JL; Schneider E; Tariot PN; Graham SM;
    Neurology; 2006 Jul; 67(1):57-63. PubMed ID: 16832078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine.
    Savaskan E; Schnitzler C; Schröder C; Cajochen C; Müller-Spahn F; Wirz-Justice A
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):507-16. PubMed ID: 16316485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist.
    Flint AJ; van Reekum R
    Can J Psychiatry; 1998 Sep; 43(7):689-97. PubMed ID: 9773218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol.
    Pelton GH; Devanand DP; Bell K; Marder K; Marston K; Liu X; Cooper TB
    Am J Geriatr Psychiatry; 2003; 11(2):186-93. PubMed ID: 12611748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.